UCABRI

Welcome to the Brand page for “UCABRI”, which is offered here for Pharmaceutical preparations for the prevention and treatment of chronic idiopathic urticaria; pharmaceutical preparations and substances for treatment and/or alleviation of rhinitis; pharmaceutical preparations and substances for treatment and/or alleviation of asthma; pharmaceutical preparations and substances for treatment and/or alleviation of respiratory ailments and chronic obstructive pulmonary disease; inhalers filled with pharmaceutical preparations for the treatment and alleviation of respiratory ailments and chronic obstructive pulmonary disease; pharmaceutical preparations and substances for treatment and/or alleviation of ige-mediated disorders; pharmaceutical preparations and substances for treatment and/or alleviation of atopic dermatitis; pharmaceutical preparations and substances for treatment and/or alleviation of psoriasis, psoriatic arthritis, rheumatoid arthritis and other musculoskeletal disorders; pharmaceutical preparations and substances for treatment and/or alleviation of systemic lupus erythematosus;.

Its status is currently believed to be active. Its class is unavailable. “UCABRI” is believed to be currently owned by “Glenmark Specialty S.A.”